Benlysta (belimumab)

pCPA File Number: 21220
Negotiation Status:
Under consideration for negotiation
Indication(s):
Systemic lupus erythematosus
Sponsor/Manufacturer:
GlaxoSmithKline
CADTH Project Number:
SR0616-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable